Pancreatic Neoplasms
Showing NaN - NaN of 10
Tumors, NSCLC, Pancreatic Tumors Trial in Worldwide (V941, Pembrolizumab)
Completed
- Neoplasms
- +3 more
- V941
- Pembrolizumab
-
Gilbert, Arizona
- +25 more
Sep 5, 2022
NSCLC, Colorectal Neoplams, Endometrial Tumors Trial in Worldwide (LY3537982, Abemaciclib, Erlotinib)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +4 more
- LY3537982
- +7 more
-
Los Angeles, California
- +21 more
Jul 22, 2022
Mesothelioma, Mesotheliomas Pleural, Mesothelioma, Malignant Trial in Bethesda, Nashville (TC-510, Fludarabine,
Recruiting
- Mesothelioma
- +14 more
- TC-510
- +2 more
-
Nashville, TennesseeSarah Cannon Research Institute
Jul 14, 2022
Adenocarcinoma, Pancreatic Tumors Trial in Saint Louis, Nashville (X-82, Everolimus)
Terminated
- Adenocarcinoma
- Pancreatic Neoplasms
-
Saint Louis, Missouri
- +1 more
Jun 15, 2021
Pancreatic Tumors Trial in Worldwide (nab-Paclitaxel, Gemcitabine, Chemoradiation)
Pancreatic Tumors Trial in United Kingdom, United States (KU-0059436 (AZD2281)(PARP inhibitor), Gemcitabine)
Completed
- Pancreatic Neoplasms
- KU-0059436 (AZD2281)(PARP inhibitor)
- Gemcitabine
-
New York, New York
- +3 more
Dec 19, 2013
Breast Tumors, Colorectal Tumors, Pancreatic Tumors Trial in Philadelphia, Nashville (SN2310 Injectable Emulsion)
Completed
- Breast Neoplasms
- +4 more
- SN2310 Injectable Emulsion
-
Philadelphia, Pennsylvania
- +1 more
Jun 2, 2009